A study on determination of Minimum Inhibitory Concentration (MIC) of Vancomycin of MRSA Isolates and their impact in treatment of MRSA Isolates
Journal Title: IP International Journal of Medical Microbiology and Tropical Diseases - Year 2017, Vol 3, Issue 1
Abstract
Introduction: Staphylococcus aureus is one of the most common causes of nosocomial infections. Methicillin-resistant S. aureus (MRSA) is among the top three clinically important pathogens. The glycopeptide vancomycin is considered to be the best alternative for the treatment of MRSA. MRSA usually exhibit vancomycin-susceptible phenotype (VSSA) but some strains exhibit reduced susceptibility to vancomycin which can be heterogeneous-intermediate (hVISA), intermediate (VISA) or fully resistant (VRSA) phenotypes which results in treatment failure. More recently, poor clinical outcome is observed in infections with MRSA strains with an elevated levels of vancomycin MIC within the susceptible range. Aim: This study was done to know the prevalence of MRSA and to determine the vancomycin MIC. Materials & Methods: S.aureus isolated from clinical samples were screened for methicillin resistance using cefoxitin discs (30 μg). The vancomycin MIC of these MRSA isolates was determined using E-strips. Results & Discussion: A total of 102 isolates of S.aureus were subjected to study. Among these, 42 isolates were MRSA (41.2%). The different MIC values are as follows: 0.38 μg/mL (2 isolate), 0.75 μg/mL (1 isolate), 1 μg/mL (3 isolates), 1.5 μg/mL (32 isolates) & 2 μg/mL (4 isolates). Although all the MRSA strains were within the susceptible range of vancomycin MIC, their increased MIC values (>1 μg/mL) can lead to treatment failures. Conclusion: Increased risks of treatment failure has been observed in infections caused by MRSA isolates with vancomycin MIC in the upper end of susceptible range (MIC > 1µg/ml), emphasising the need for determination of vancomycin MIC to assess the treatment outcome.
Authors and Affiliations
Mathavi Suresh Kumar, Vijai Radhika, Kavitha A, Sasikala G, Indra Priyadharsini
Keywords
Related Articles
- EP ID EP305097
- DOI 10.18231/2455-6807.2017.0004
- Views 135
- Downloads 0
Microbiological profile of leucorrhoea in patients attending a tertiary care hospital at Jalna
Introduction and Objective: Leucorrhoea is an abnormal white, yellow or greenish vaginal discharge associated with irritation, is non-hemorrhagic in nature and signifies some underlying pelvic pathology. It is common com...
Anti-biogram of pneumococcal isolates in a tertiary care hospital
Streptococcus pneumoniae are gram positive normal flora of the upper respiratory tract in humans but are also the primary causative bacterial agents of pneumonia and otitis media mostly in children They are also known to...
Phenotypic and genotypic characterization of multidrug-resistant salmonella in a tertiary care hospital
This is a prospective laboratory based observational study on genotypic and phenotypic characterization of multidrug resistant salmonella conducted over a period of 1 year in a tertiary care hospital. About 2280 blood sa...
Bacteriological profile in UTI Cases with special reference to Amikacin sensitivity in a tertiary Care centre in Western UP
Introduction UTI is the most common bacterial infection worldwide with adult women being 30 times more likely to suffer from it than men due to short urethra and proximity of uretheral opening with anal canal Escherichia...
Phenotypic detection of ESBL among E.coli and Klebiella pneumoniae by CLSI guidelines in a Teaching Hospital MIMS, Mandya
Introduction Escherichia coli and Klebsiella pneumoniae cause a wide range of infections Multidrugresistance strains carrying resistance genes have become a growing problem worldwide The ESBLs have emerged distinctly esp...